WX-037

· Heidelberg Pharma AG

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for WX-037, covering 2014-05-16 to 2014-05-16. Get the full timeline:

Most recent: Clinical Trial Update: Phase I Study of WX-037 Alone and in Combination With WX-554 in Solid Tumours [Phase 1]